Chindex International, a US company that provides healthcare services and supplies medical devices to the Chinese market, has entered into a contract to supply $7.12 million in laboratory and hospital products to Centers for Disease Control (CDC) in Qinghai Province. The purchase is being financed by the KfW Development Bank of Germany under a government to government program. The signing ceremony was held in Beijing and the contract is expected to ship during the current fiscal year. Mr Roberta Lipson, Chindex President and CEO, said: Chindex continues to be a key supplier under the KfW program\\\'s CDC efforts in China. We are pleased to once again be implementing another KfW program, utilizing the expertise that we have developed in government-sponsored loan projects, to provide an increasingly diversified and robust array of medical and laboratory products to China\\\'s healthcare communities. |